UroGen Pharma Statistics
NASDAQ: URGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
36.98-3.72 (-9.14%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
UroGen Pharma by the numbers
UroGen Pharma has a market capitalization of $1.81 billion based on 48.88M shares outstanding. With trailing EPS of $-1.97, UroGen Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.6% below its 50-day average and 22.1% above its 200-day average.
Average daily trading volume is 849.01K shares, or about $31.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
URGN valuation vs. peer median
| Metric | URGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.81B | $1.82B | -1% |
| Avg. volume | 849.01K | 1.67M | -49% |
Peer median across 8 companies: ZYME, BHVN, GENB, XNCR, TRVI, GPCR, XERS, NUVB.
Valuation
- Market cap
- $1.81B
- Forward P/E
- 13.23
- Price / sales (latest FY)
- 16.46
- EPS (TTM)
- $-1.97
- Shares outstanding
- 48.88M
Price and trading
- Previous close
- 40.70
- Open
- 39.93
- Day range
- 34.18 – 40.05
- 52-week range
- 15.86 – 50.81
- 52-week change
- +113.39%
- Beta
- —
- Volume
- 2.02M
- Average volume
- 849.01K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.81B
- Forward Pe
- 13.23
- Eps
- -1.97
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 50.81
- Week52 Low
- 15.86
- Avg Volume
- 849.01K
- Shares Outstanding
- 48.88M
- Ma50
- 43.79
- Ma200
- 30.28
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -27.22%
- Pct From52w Low
- 133.17%